Aurobindo Pharma Usa, Inc.

Add value through superior customer service in the distribution of a broad line of generic pharmaceuticals, leveraging vertical integration and efficient controlled processes. To become a consistent top 10 generic pharmaceutical supplier with a reputation for superior customer service, honesty and transparency. Understand our business, our industry, and what is important to our customers; stay current and informed. Anticipate and understand the impact of our actions on the customer Strive for 100% accuracy in all customer-related activities including orders, shipments, and correspondence Our people are what makes APUSA. We will continuously develop and grow our employees Focus on the long term health of the company vs. short-term gains Opened 567,000 sq. ft. fully automated state-of-art distribution center in East Windsor, NJ Opened a new, 40,000 sq. ft. specialty pharma R&a;D facility in Durham, NC APL acquired 4 cell culture-derived biosimilar products from Swiss TL Biopharmaceutical. Three out of the four biosimilars are monoclonal antibodies in oncology. Aurobindo Pharma USA, Inc. moves Corporate Headquarters to East Windsor, NJ, USA Aurohealth LLC begins doing business in Lawrenceville, NJ, USA Focus on differentiated technology platforms eg. depot injections APL acquires commercial operations in Western Europe from Actavis making it one of the leading Indian pharmaceutical companies in Europe. Commenced operations of SEZ Unit VII and Aurolife, USA facilities and divested Chinese antibiotics products facility Aurolife Pharma LLC begins manufacturing solid oral dose. Acquired building from Sandoz to begin Aurolife Manufacturing in Dayton, NJ, USA